Spring 2003
Dr. Richard Zaino Receives Distinguished Educator Award
Richard J. Zaino, M.D., Professor of Pathology, was chosen as a winner of
the Distinguished Educator Award for 2002-2003. Dr. Zaino was
honored on May 19, 2003, at the First Annual Distinguished Educator Awards
presented here at Penn State College of Medicine.
He was one of ten exemplary faculty members who were recognized
for demonstrating exceptional scholarly work in medical and/or graduate
education. A Society of Master Educators will be formed to include
these award winners.
Dr. Loren Clarke Receives Resident Teaching Award
Loren Clarke, M.D., Resident 2, received the 2003 Arnold P. Gold
Foundation's Humanism and Excellence in Teaching Award. The Class of
2004 chose six residents who have demonstrated exceptional teaching skills and
are role models for compassionate, relationship-centered care. He
received this award at the Student Clinician Ceremony on June 19, 2003.
HIPAA Training Sessions
ALL faculty and staff are required to attend HIPAA (Health Insurance
Portability and Accountability Act) training before April 14, 2003!
It is important to recognize what is termed “Identifiable Information” -
health information that could be used alone or in combination with other
information that might allow for identification of a patient’s protected
health information. Remember to disclose these identifiers for treatment,
payment and operational purposes only, and to keep documents containing any
of these identifiers from public view. The list of identifiers is as follows:
-
Name
-
Address
-
Zip code
-
Dates – birth, admission, discharge,
treatment
-
Telephone Number
-
Fax Number
-
Email Address
-
Health Plan Number
-
Account Number
-
Certificate/License Number
-
Social Security Number
-
Medical Record Number
-
Web Universal Resource Locators (URLs)
-
Medical Device Identifiers
-
Vehicle Identifiers
-
Internet Protocol (IP) Address
-
Finger and Voice Prints
-
Full Face Photos
New to the Automated Testing Lab
BNP - B-type Natriuretic Peptide is used as an aid in the
diagnosis and assessment of severity of congestive heart failure. It is also
used for the risk stratification of patients with acute coronary syndromes. The
test is run on a Triage Meter, which is a point of care device. The normal range
is <100 pg/ml. It is expected that the main use will be in the E.D. when they
have a patient that is in respiratory distress and they need to rule out
congestive heart failure
HsCRP - High sensitive CRP (hsCRP) is the newest test for
cardiac risk assessment. It is the same CRP or C-Reactive Protein that has been
used for years as an indicator of inflammation. The new test detects CRP at very
low levels. If there has been buildup of plaque in the arteries, there may be
very low levels of inflammation. Normal CRP tests detect down to 2.0 mg/dl. The
new hsCRP method detects down to levels of 0.05 mg/dl. A value of <0.07 is
considered normal. Values between 0.07 and 0.17 are considered moderate cardiac
risk. This test has had lots of press lately and it is recommended that it be
used like Cholesterol and HDL for cardiac risk assessment in certain patients.
Because this test does detect inflammation from other sources the results need
to be interpreted with care.
Architect XR - The Automated Testing lab has just
received a new Abbott Architect. This is an immunochemistry analyzer that does Thyroid tests, CEA, Progesterone, etc. We already have one analyzer, however,
the new one has a special specimen handling track on it that improves specimen
handling and allows for stats and easier repeats. The analyzer also comes with
enhanced software. We are the first U.S. customer to use this analyzer in a
clinical setting.
Back to News & Events
|